CapyFin

Calendar Reports Pricing

Search for a symbol...

Loading...

CapyFin Real-time Earnings Reports.

Products

Earnings
API

Get in Touch

Contact Us
X (Twitter)
LinkedIn

Resources

Privacy Policy
Terms of Service
Sign Up
Sign In

© 2026 CapyFin. All rights reserved.

Disclaimer: CapyFin provides financial data and AI analysis for informational purposes only and does not provide investment advice or recommendations. Real-time data and AI outputs may be inaccurate, incomplete, delayed, or contain errors or hallucinations. Investing involves risk, including loss of principal. The service is provided “as is” and we disclaim liability to the fullest extent permitted by law. See our Terms of Service and Privacy Policy.

Cytokinetics (CYTK) Financial Analysis | CapyFin

Cytokinetics

CYTK · NASDAQ🇺🇸

Earnings Dividends Seasonality Metrics

Reported earnings about 1 month ago

Previous year: $16.9M

Previous year: -$1.26

Previous year: $93.6M

Previous year: $62.3M

Net Cash Utilization

Cash and Equivalents

Previous year: $1.08B

Previous year: $1.4B

Loading...

Cytokinetics

Unlock previous datapoints

Cytokinetics

Unlock previous datapoints

Cytokinetics Revenue by Segment

Revenue by Segment

Collaboration Revenues Revenue

CapyFin.com

License and Milestone Revenue

CapyFin.com

Historical Earnings Impact

Analyze how earnings announcements historically affect stock price performance

Avg. Return Before/After Earnings

Loading earnings performance data...

Loading earnings reaction data...

Key Statistics

Market Cap

$7.7B

P/E Ratio

-11.45

Sector

N/A

Industry

N/A

52-Week High

$70

52-Week Low

$29.8

R&D Expenses

$104M

G&A Expenses

$91.7M

Net Cash Utilization

$134M